ARL16 is an ARF-family GTPase that operates as a GTP-dependent regulatory switch in two distinct cellular contexts (PMID:21233210, PMID:35196065). In innate immunity, GTP-loaded ARL16 binds the C-terminal domain of RIG-I and suppresses RIG-I association with viral RNA, thereby negatively regulating type I interferon signaling; GDP-restricted mutants (T37N, Δ45-54) fail to bind RIG-I or inhibit its signaling, establishing that nucleotide-dependent activation is required for both the interaction and its inhibitory function (PMID:21233210). In ciliated cells, ARL16 is required for a Golgi-to-cilia trafficking pathway that specifically exports IFT140 and INPP5E to cilia: its loss reduces ciliogenesis, depletes ARL13B, ARL3, INPP5E, and IFT140 from cilia, and causes INPP5E and IFT140 to accumulate at the Golgi (PMID:35196065). In this pathway ARL16 acts downstream of or in parallel with the ARF GAPs ELMOD1 and ELMOD3, since an activating ARL16 mutant rescues the ciliary defects of ELMOD1 or ELMOD3 deletion (PMID:34818063). The biochemical mechanism linking these two roles and the direct effectors of ARL16 in cilia have not been characterized in the available corpus.